Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of “Buy” by Analysts

Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have earned a consensus rating of “Buy” from the five ratings firms that are presently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued ratings on the stock […]

Leave a Reply

Your email address will not be published.

Previous post McGraw Hill, Inc. (NYSE:MH) Given Average Recommendation of “Moderate Buy” by Brokerages
Next post Nuveen LLC Invests $11.83 Million in M/I Homes, Inc. $MHO